These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3022433)

  • 1. Treatment of visceral leishmaniasis in Bihar.
    Thakur CP
    Trop Doct; 1986 Oct; 16(4):146-7. PubMed ID: 3022433
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment for visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1987 Sep; 35(9):641-3. PubMed ID: 2830224
    [No Abstract]   [Full Text] [Related]  

  • 3. Visceral leishmaniasis unresponsive to antimonial drugs. II. Response to high dosage sodium stibogluconate or prolonged treatment with pentamidine.
    Bryceson AD; Chulay JD; Mugambi M; Were JB; Gachihi G; Chunge CN; Muigai R; Bhatt SM; Ho M; Spencer HC
    Trans R Soc Trop Med Hyg; 1985; 79(5):705-14. PubMed ID: 3006295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kala-azar: unresponsiveness to prolonged sodium stibogluconate therapy.
    Bhattacharya D; Majhi TK; Dutta RK
    J Assoc Physicians India; 1987 Jul; 35(7):543. PubMed ID: 2828305
    [No Abstract]   [Full Text] [Related]  

  • 5. Sodium antimony resistant cases of kala-azar in and around Patna (south Bihar).
    Sehgal PN; Murmu C; Chatteyee AK
    J Commun Dis; 1988 Jun; 20(2):161-2. PubMed ID: 2853714
    [No Abstract]   [Full Text] [Related]  

  • 6. An in vitro model for investigation of chemotherapeutic agents in leishmaniasis.
    Berman JD; Wyler DJ
    J Infect Dis; 1980 Jul; 142(1):83-6. PubMed ID: 6249874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methylglucamine antimoniate and sodium stibogluconate in the treatment of leishmaniasis. Study of 16 cases].
    Bourée P; Anciaux ML; Taugourdeau P
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):607-10. PubMed ID: 3003657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of allopurinol and pentostam in the treatment of visceral leishmaniasis.
    Tobaigy M; Mejer J; Peitersen B; Ansari M; Poll P
    Adv Exp Med Biol; 1986; 195 Pt A():471-3. PubMed ID: 3014837
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of visceral leishmaniasis.
    Thakur CP
    J Assoc Physicians India; 1985 May; 33(5):379-80. PubMed ID: 2995305
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antimony content of the thyroid of man and animals undergoing visceral leishmaniasis treatment with the organic compound of antimony, stibogluconate sodium].
    Fuzaĭlov IuM
    Med Parazitol (Mosk); 1982; 51(1):62-5. PubMed ID: 6278277
    [No Abstract]   [Full Text] [Related]  

  • 11. Kala-azar in Bihar.
    Prasad LS
    Indian J Pediatr; 1987; 54(1):103-10. PubMed ID: 3030932
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
    Thakur CP; Kumar M; Kumar P; Mishra BN; Pandey AK
    Br Med J (Clin Res Ed); 1988 Jun; 296(6636):1557-61. PubMed ID: 2840172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Action of p-(4-amidino-phenoxy)-benzaldehyde-p-amidino-phenylhydrazone dihydrochloride on Leishmania donovani infections in the golden hamster.
    Raether W; Seidenath H; Loewe H
    Ann Trop Med Parasitol; 1978 Dec; 72(6):543-7. PubMed ID: 216324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of visceral leishmaniasis.
    Wali JP; Sharma SK; Guleria JS
    J Assoc Physicians India; 1984 Sep; 32(9):813-4. PubMed ID: 6096351
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged sodium stibogluconate therapy in Indian kala-azar.
    Jha TK; Sharma VK
    J Assoc Physicians India; 1986 Jul; 34(7):469-71. PubMed ID: 3019993
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
    Black CD; Watson GJ; Ward RJ
    Trans R Soc Trop Med Hyg; 1977; 71(6):550-2. PubMed ID: 204085
    [No Abstract]   [Full Text] [Related]  

  • 17. Complications of kala azar and its treatment in Kenya.
    Chunge CN; Gachihi G; Chulay JD; Spencer HC
    East Afr Med J; 1984 Feb; 61(2):120-7. PubMed ID: 6088210
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical, haematological and parasitological response to treatment of visceral leishmaniasis in Kenya. A study of 64 patients.
    Kager PA; Rees PH; Manguyu FM; Bhatt KM; Wellde BT; Hockmeyer WT; Lyerly WH
    Trop Geogr Med; 1984 Mar; 36(1):21-35. PubMed ID: 6328709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphotericin B in visceral leishmaniasis.
    Jha BB
    Indian Pediatr; 1996 Nov; 33(11):971. PubMed ID: 9141838
    [No Abstract]   [Full Text] [Related]  

  • 20. Liposomal dosage form development--some practical considerations.
    Rao LS
    J Parenter Sci Technol; 1983; 37(3):72-5. PubMed ID: 6308198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.